VUMC To Test Whether Alzheimer's Drug Can Ease Lupus Symptoms
October 08, 2022
October 08, 2022
NASHVILLE, Tennessee, Oct. 8 (TNSres) -- Vanderbilt University Medical Center issued the following news:
Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer's drug, memantine, can improve cognitive symptoms associated with systemic lupus erythematosus (SLE), an autoimmune disease.
The external licensing and clinical trial agreement to "repurpose" a drug already on the market for a new use, signe . . .
Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer's drug, memantine, can improve cognitive symptoms associated with systemic lupus erythematosus (SLE), an autoimmune disease.
The external licensing and clinical trial agreement to "repurpose" a drug already on the market for a new use, signe . . .